Skip Ribbon Commands
Skip to main content
Translate
Translate
menu iconMenu
search iconSearch

Leukemia Society Awards Top Grant To Moores UCSD Cancer Center Researcher

 

November 10, 2005  |  

The Leukemia and Lymphoma Society has awarded Thomas Kipps, MD, PhD, Deputy Director of Research at the UC San Diego Moores Cancer Center, a $6.25 million, 5-year grant to develop new blood-cancer therapies. Kipps, an international authority on chronic lymphocytic leukemia (CLL), is one of only four new Specialized Center of Research (SCOR) grant recipients named this year.

SCOR grants are the largest grants the Leukemia and Lymphoma Society makes. There are only 15 active SCOR sites in the world.

Thomas Kipps, MD, PhD

Thomas Kipps, MD, PhD

“I feel very fortunate to have been named an awardee,” said Kipps, professor of medicine at the UC San Diego School of Medicine and director of a national CLL research consortium based at the Cancer Center. “We have some exciting leads to develop treatments that may benefit patients who have failed standard treatment, and that may even lead to a cure. The lessons learned from this work may apply to other leukemias and perhaps some solid tumors as well.”

The SCOR program encourages scientists from different disciplines to collaborate in the hope of developing novel treatments. Awards to go those groups that best demonstrate outstanding scientific promise and the synergy that will occur from their combined efforts.

Led by extraordinary scientific innovators, SCOR teams include some of the brightest medical researchers in the field of blood cancers – specialists in genetics, cell biology, virology, immunology and other areas.

The team that Kipps has assembled will focus on identifying new targeted therapies for CLL. His team, which includes scientists from UC San Diego and the Burnham Institute, will work on four avenues of attack: development of drugs targeting a protein called ZAP-70 that is found in aggressive CLL; development of therapies that eliminate the resistance of leukemia cell death; evaluating the role of a pro-inflammatory protein, called NF-kB, in CLL progression; and testing the ability of the newly developed drugs to trigger leukemia cell death.

In addition to Kipps, project leaders on the SCOR grant from UC San Diego are Dennis Carson, MD, Paul Insel, MD, and Michael Karin, PhD; and from the Burnham Institute, John Reed, MD, PhD

The Rebecca and John Moores UC San Diego Cancer Center is one of just 39 centers in the United States to hold a National Cancer Institute (NCI) designation as a Comprehensive Cancer Center. As such, it ranks among the top centers in the nation conducting basic and clinical cancer research, providing advanced patient care and serving the community through outreach and education programs.

#  #  #

News Media Contact: Nancy Stringer, 619-543-6163, nstringer@ucsd.edu

Note to broadcast and cable producers: UC San Diego provides an on-campus satellite uplink facility for live or pre-recorded television interviews.  Please
phone, or e-mail, the media contact listed above to arrange an interview.




Media Contact

Related News

4/22/2015
UC San Diego Health System and Scripps Health are partnering to provide improved continuity of patient care, fellowship training and research in hospice and palliative medicine. Under a new five-year ...
4/20/2015
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have discovered a molecular mechanism that connects breast tissue stiffness to tumor metastasis and p ...
4/20/2015
A decrease in the amount of time spent eating and an increase in overnight fasting reduces glucose levels and may reduce the risk of breast cancer among women, report University of California, San Die ...
4/20/2015
The threat of falsified medications, also referred to as counterfeit, fraudulent, and substandard, can be quite real, yet the full scope and prevalence of the problem is poorly understood, say researc ...
4/17/2015
Researchers at the University of California, San Diego School of Medicine have created an in vitro, live-cell artificial vessel that can be used to study both the application and effects of devices us ...
4/16/2015
The increase in use of e-cigarettes has led to heated debates between opponents who question the safety of these devices and proponents who claim the battery-operated products are a useful cessation t ...
4/16/2015
An international team of scientists, led by researchers at University of California, San Diego School of Medicine, have found genetic overlap between Alzheimer’s disease (AD) and two significant cardi ...
4/13/2015
About one quarter of all atrial fibrillation patients at the lowest risk for stroke receive unnecessary blood thinners from cardiology specialists, according to a new study by researchers at Universit ...


Share This Article



Follow Us: